For over two years, the COVID-19 pandemic has put both public health systems and the public at large to an excruciating test. The need for governments and the citizens they represent to heed the advice of experts to help slow the spread of the disease remains as urgent as ever in order to ease the enormous burden being placed on hospitals and healthcare workers around the world. Although the public research institutes and pharmaceutical industry have been successful in producing vaccines against COVID-19, and with doses of being administered at impressive rates in many high-income countries, these remain out of reach for the vast majority of people in low- and middle-income countries (LMICs). To avoid prolonging the pandemic, and to mitigate the risk of evermore variants appearing, it is essential that we achieve equitable access to vaccines now. 

On this page, you will find more information about the work HAI is doing to help ensure the affordability and accessibility of treatments for COVID-19, as well as the impact and mitigation of challenges related to all our programmes.